Short answer: The MSN article is based on a real scientific study, but the headline "Psychedelic drug may slow aging" is stronger than the evidence currently supports. The research is interesting and legitimate, but it is preclinical (cells and mice), not proof that psilocybin slows aging in humans. [msn.com], [news.emory.edu]

What is true?

The underlying study, published in npj Aging by researchers associated with Emory University and Baylor College of Medicine, found that:

• Psilocin (the active metabolite produced after taking psilocybin) increased the lifespan of cultured human skin and lung cells by more than 50% in laboratory experiments. [news.emory.edu], [nature.com]
• In aged mice (roughly equivalent to humans aged 60–65 years), those receiving psilocybin treatment had a higher survival rate than untreated mice over the study period. [news.emory.edu], [sciencedaily.com]
• Researchers reported biological markers consistent with slower cellular aging, including reduced oxidative stress, improved DNA repair responses, and preservation of telomere length. [news.emory.edu], [nature.com]

What is exaggerated or uncertain?

The article's implication that psilocybin may slow aging in people is not yet established.

Key limitations:

1. No human longevity data exist. The study was performed in cell cultures and mice, not humans. [news.emory.edu], [nature.com]
2. Many mouse anti-aging interventions fail in humans. Animal results often do not translate into clinically meaningful life extension. This is a common issue in aging research. [nature.com], [sciencedaily.com]
3. The doses used in mice may not correspond neatly to safe or practical human dosing schedules. [news.emory.edu], [sciencedaily.com]
4. The study has generated excitement, but independent replication and human trials are still needed. Researchers themselves describe the work as opening a new avenue for investigation rather than proving an anti-aging treatment. [news.emory.edu], [sciencedaily.com]

My verdict

For someone interested in longevity

I'd rank this evidence roughly alongside many other early-stage longevity findings: scientifically intriguing but far from actionable. Compared with interventions such as exercise, blood pressure control, maintaining healthy weight, avoiding smoking, vaccination, and managing cardiovascular risk factors, the evidence for psilocybin as an anti-aging therapy is still extremely preliminary. The study is worth watching, but it is not yet a reason to use psilocybin for longevity purposes. [news.emory.edu], [nature.com]

Bottom-line fact check: The article is based on a real peer-reviewed study and accurately reports the mouse/cell findings, but readers should not interpret it as evidence that psilocybin slows aging in humans.